The effects of goutweed (Aegopodium podagraria L.) tincture on the background of toxic doses of allopurinol with the excessive intake of purine derivatives and proteins

O. V. Tovchiga

Abstract


There is an increasing interest in the use of herbal preparations as part of the combined therapy, including cases of hyperuricemia and gout. Preparations of goutweed (Aegopodium podagraria L.) aerial part are characterized by organoprotective and favorable metabolic effects, including the effect on the uric acid metabolism largely related to hydroxycinnamic acids. Allopurinol continues to be the most widely used hypouricemic drug.
Aim. To characterize the renal, metabolic, and psychotropic effects of goutweed tincture combined with allopurinol in rats under the conditions of the excessive intake of purine derivatives and proteins.
Materials and methods. The experiments were performed on the background of the excessive intake of purine derivatives and proteins in rats (10-day administration of the yeast extract in the dose of 10 g/kg with addition of molybdenum in the amount of 0.3 mg per animal and i/p injection of inosine in the dose of 50 mg/150 g). Goutweed tincture (1 ml/kg), allopurinol (50 mg/kg) and their combination were administered intragastrically during the whole period of the studies. The state of the excretory renal function, biochemical parameters of the blood plasma, the activity of xanthine oxidase (CSR) and the content of uric acid in the liver and kidneys, as well as the state of the CNS in the combined open field and an elevated plus maze tests were studied.                  Results. The renal injury on the background of excessive purine derivatives and proteins was verified by the criteria of hyperfiltration with increased water reabsorption and reduced ability of the kidney to excrete water load, a decrease in urea clearance and an increase of proteinuria. The level of urea and nitrogen of amino groups of the low-molecular compounds in the blood plasma increased in the absence of changes in creatininemia and uricemia (with a marked increase of renal excretion of uric acid on the background of the liver xanthine oxidase increased activity). Under the conditions of the excessive intake of purine derivatives and proteins goutweed tincture provided effective excretion of potassium, normalized the total protein content in the blood, as well as urea clearance without affecting other parameters and not leading to toxic effects. It also did not change the uric acid content and the xanthine oxidase activity of the liver and kidneys. On the background of allopurinol, the severity of the kidney damage increased with the threefold increase in the relative kidney weight, hyperazotemia, an abrupt decrease in GFR and urea clearance, reabsorption decrease, a tendency to increase in natriemia and, especially kalemia, a significant increase of proteinuria, as well as an increase in the total protein content in the blood. Goutweed tincture did not enhance the toxicity of allopurinol and did not prevent xanthine oxidase inhibition. It exerted the marked antiproteinuric effect, maintained sodium reabsorption, leading to the decrease in its excretion, reduced natriemia on the background of normokalemia. The tincture reduced the anxiety of animals in the elevated plus maze test, this effect was evident when the tincture was combined with allopurinol; in this case the intensity of vegetative and emotional signs in the open field test was also reduced.                                                              Conclusions. Goutweed tincture does not enhance the toxicity of allopurinol under the conditions of the excessive intake of purine derivatives and proteins.


Keywords


rats; kidneys; goutweed (Aegopodium podagraria L.); allopurinol; xanthine oxidase; uric acid

GOST Style Citations


1. MacFarlane, L. A. Gout : a review of nonmodifiable and modifiable risk factors / L. A. MacFarlane, S. C. Kim // Rheum. Dis. Clin. North. Am. – 2014. – Vol. 40, Issue 4. – P. 581–604.

2. Multinational evidence–based recommendations for the diagnosis and management of gout : integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative / F. Sivera, M. Andrés, L. Carmona et al. // Ann. Rheum. Dis. – 2013. – Vol. 73, Issue 2. – P. 328–335. doi: 10.1136/annrheumdis–2013–203325

3. Therapeutic risk and benefits of concomitantly using herbal medicines and conventional medicines : from the perspectives of evidence based on randomized controlled trials and clinical risk management / X. L. Zhang, M. Chen, L. L. Zhu, Q. Zhou // Evid. Based Complement. Alternat. Med. –2017. – Vol. 2017. – P. 1 – 17. doi: 10.1155/2017/9296404

4. Choi, H. K. Coffee consumption and risk of incident gout in women : the Nurses’ Health Study / H. K. Choi, G. Curhan // Am. J. Clin. Nutr. – 2010. – Vol. 92, Issue 4. – P. 922–927. doi: 10.3945/ajcn.2010.29565

5. Study on the anti–gout activity of chlorogenic acid : improvement on hyperuricemia and gouty inflammation / Z. Q. Meng, Z. H. Tang, Y. X. Yan et al. // Am. J. Chin. Med. – 2014. – Vol. 42, Issue 06. – P. 1471–1483. doi: 10.1142/s0192415x1450092x

6. Identification of crypto– and neochlorogenic lactones as potent xanthine oxidase inhibitors in roasted coffee beans / S. Honda, Y. Miura, A. Masuda, T. Masuda // Biosci. Biotechnol. Biochem. – 2014. – Vol. 78, Issue 12. – P. 2110–2116. doi: 10.1080/09168451.2014.946397

7. Койро, О. О. Вплив препаратів яглиці звичайної (Aegopodium podagraria L.) та 3–о–галактозиду кемпферолу на обмін сечової кислоти в мишей у нормі та за гіперурикемії / О. О. Койро, С. Ю. Штриголь // Фармакол. та лік. токсикол. – 2012. – № 3. – С. 47–52.

8. Койро, О. О. Роль біологічно активних речовин яглиці звичайної (Aegopodium podagraria L.) у нефропротекторній, гепатопротекторній та гіпоурикемічній дії : автореф. дис. ... канд. фарм. наук / О. О. Койро. – Х., 2014. – 20 с.

9. Товчига, О. В. Дослідження сечогінної, нефропротекторної, гіпоурикемічної дії яглиці звичайної (Aegopodium podagraria L.) як основа для створення лікарських засобів : автореф. дис. ... канд. фарм. наук / О. В. Товчига. – Х., 2009. – 21 с.

10. Дисфункция щитовидной железы при экспериментальной гиперурикемии / Ю. И. Николенко, В. Ю. Николенко, Г. А. Игнатенко, И. В. Мухин // Биомедицинская химия. – 2005. – Т. 51, № 1. – С. 72–75.

11. Мухин, И. В. Системная энзимотерапия экспериментального подагрического гломерулонефрита / И. В. Мухин // Укр. ревматол. журн. – 2001. – № 1 (3). – С. 1–3.

12. Chen, G. L. Effect and mechanism of total saponin of Dioscorea on animal experimental hyperuricemia / G. L. Chen, W. Wei, S. Y. Xu // Am. J. Chin. Med. – 2006. – Vol. 34, Issue 01. – P. 77–85. doi: 10.1142/s0192415x06003655

13. Interaction between purine and benzodiazepine : Inosine reverses diazepam–induced stimulation of mouse exploratory behavior / J. N. Crawley, P. J. Marangos, S. M. Paul et al. // Science. – 1981. – Vol. 211, Issue 4483. – P. 725–727. doi: 10.1126/ science.6256859

14. Tovchiga, O. The influence of oxonate–induced hyperuricemia and allopurinol on behavioral reactions of random–bred mice / O. Tovchiga, S. Shtrygol // J. Basic Clin. Physiol. Pharmacol. – 2012. – Vol. 23, Issue 4. – P. 1–5. doi: 10.1515/jbcpp–2012–0027

15. Karve, A. V. Evaluation of effect of allopurinol and febuxostat in behavioral model of depression in mice / A. V. Karve, S. S. Jagtiani, K. A. Chitnis // Indian J. Pharmacol. – 2013. – Vol. 45, Issue 3. – 244 p. doi: 10.4103/0253–7613.111922

16. Effects of chlorogenic acid, caffeine, and coffee on behavioral and biochemical parameters of diabetic rats / N. Stefanello, R. Schmatz, L. B. Pereira et al. // Mol. Cell Biochem. – 2013. – Vol. 388, Issue 1–2. – P. 277–286. doi: 10.1007/s11010–013– 1919–9

17. Salama, A. A. Neurotherapeutic effect of allopurinol against brain injury in hyperlipidemic rats / A. A. Salama, B. M. Ibrahim // Afr. J. Pharm. Pharmacol. – 2015. – Vol. 9, Issue 22. – P. 567–575. doi: 10.5897/ajpp2014.4247

18. Mohammed, N. E. Effect of amlodipine, lisinopril and allopurinol on acetaminophen–induced hepatotoxicity in rats / N. E. Mohammed, B. A. Messiha, A. A. Abo–Saif // Saudi Pharm. J. – 2016. – Vol. 24, Issue 6. – P. 635–644. doi: 10.1016/j. jsps.2015.04.004

19. Wexler, B. C. Allopurinol–induced myocardial and renal damage in nonarteriosclerotic (virgin) and arteriosclerotic (breeder) Sprague–Dawley rats / B. C. Wexler, B. P. Greenberg // Proc. Soc. Exp. Biol. Med. – 1978. – Vol. 157, Issue 4. – P. 541–549. doi: 10.3181/00379727–157–40093

20. Fujitani, T. Biochemical studies on the mineral components in sake yeast / T. Fujitani // Agric. Biol. Chem. – 1965. – Vol. 29, Issue 5. – P. 471–485. doi: 10.1080/00021369.1965.10858409

21. Рябов, С. И. Функциональная нефрология / С. И. Рябов, Ю. В. Наточин. – СПб. : Лань, 1997. – 304 с.

22. Urinary excretion of purine derivatives and tissue xanthine oxidase (EC 1.2.3.2) activity in buffaloes (Bubalis bubalis) with special reference to differences between buffaloes and Bos taurus cattle / X. B. Chen, L. Samaraweera, D. J. Kyle et al. // Br. J. Nutr. – 1996. – Vol. 75, Issue 03. – 397 p. doi: 10.1079/bjn19960142

23. Осадчая, Л. М. Методы изучения состава и метаболизма липидов тканей / Л. М. Осадчая; под ред. М. И. Прохоровой // Методы биохимических исследований (липидный и энергетический обмен). – Л. : Ленинградский университет, 1982. – 272 с.

24. Шейман, Д. А. Патофизиология почки / Д. А. Шейман. – М. : БИНОМ; СПб. : Невский диалект, 1999. – 206 с.

25. Utilization of spent brewer’s yeast Saccharomyces cerevisiae for the production of yeast enzymatic hydrolysate / M. Bayarjargal, E. Munkhbat, T. Ariunsaikhan et al. // Mongol. J. Chem. – 2014. – Vol. 12. – P. 88–91. doi: 10.5564/mjc.v12i0.179

26. Hyperuricemia model induced by yeast in mice / G. L. Chen, Q. L. Zhang, X. Q. Ma, S. Y. Xu // Chinese Pharm. Bull. – 2003. – Vol. 4. – 332 p.

27. Uric acid. Handbook of Experimental Pharmacology / ed. W. N. Kelley, I. M. Weiner. – Berlin, Heidelberg, New York : Springer– Verlag, 1978. – 504 p.

28. Goutweed (Aegopodium podagraria L.) biological activity and the possibilities of its use for the correction of the lipid metabolism disorders / O. V. Tovchiga, O. O. Koyro, S. I. Stepanova et al. // Харчова наука і технол. – 2017. – Т. 11, № 4. – С. 9–20. doi: 10.15673/fst.v11i4.726

29. Hasko, G. Immunomodulatory and neuroprotective effects of inosine / G. Hasko, M. V. Sitkovsky, C. Szabo´ // Trends Pharm. Sci. – 2004. – Vol. 25, Issue 3. – P. 152–157. doi: 10.1016/j.tips.2004.01.006

30. Tovchiga, O. The influence of Aegopodium podagraria L. extract and tincture on behavioural reactions of random–bred mice / O. Tovchiga, S. Shtrygol’ // J. Chem. Pharm. Res. – 2015. – Vol. 7, Issue 7. – P. 370–384.

31. Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects / J. Bouayed, H. Rammal, A. Dicko et al. // J. Neurol. Sci. – 2007. – Vol. 262, Issue 1–2. – P. 77–84. doi: 10.1016/j.jns.2007.06.028





DOI: https://doi.org/10.24959/cphj.18.1451

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Abbreviated key title: Klìn. farm.

ISSN 2518-1572 (Online), ISSN 1562-725X (Print)